Richard J. Berman - 27 Aug 2024 Form 4 Insider Report for Celularity Inc (CELU)

Reporting relationship: Director
Issuer ticker: CELU
Reported as of: 27 Aug 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Aug 2024, 17:26:27 UTC
Prior SEC filing: 14 Jun 2024
Next SEC filing: 07 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ K. Harold Fletcher, Attorney-in-Fact

Key filing fact

Richard J. Berman filed Form 4 for Celularity Inc (CELU) on 28 Aug 2024.

Key facts

This page summarizes Richard J. Berman's Form 4 filing for Celularity Inc (CELU).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Aug 2024, 17:26.

Change

Previous filing in this sequence was filed on 14 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CELU transaction Derivative

Stock Option Grant (Right to Buy)

Award

Transaction value: $0
Shares: +118,111
Change %
Price: $0.000000
Shares after: 118,111
Date: 27 Aug 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 118,111
Exercise price: $3.01
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in three successive equal annual installments measured from the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date.